CRISPR Therapeutics (CRSP) PT Raised to $84 at Canaccord Genuity

June 15, 2020 11:04 AM EDT Send to a Friend

Canaccord Genuity analyst Arlinda Lee ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

CRISPR Therapeutics (CRSP) PT Raised to $84 at Canaccord Genuity

Member Login

Free News Feed